AM Best to Sponsor 2023 International Conference on Inclusive Insurance
LONDON–(BUSINESS WIRE)–#insurance—AM Best will sponsor the International Conference on Inclusive Insurance, which will be held 23-27 October 2023... Read more.
EMD Serono to Present Latest Research from Oncology Portfolio at ESMO 2023
Not intended for UK-based media ROCKLAND, Mass.–(BUSINESS WIRE)–EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany in the US and Canada,... Read more.
KKR and Flerie Form Specialized Pharma Services Platform Frontier Biosolutions and Invest in Coriolis Pharma
KKR and Flerie to support organic and inorganic growth to extend Coriolis’ leadership position in formulation development and analytical services for innovative... Read more.
Merck to Present Latest Research from Oncology Portfolio at ESMO 2023
Not intended for UK-, US- or Canada-based media DARMSTADT, Germany–(BUSINESS WIRE)–Merck, a leading science and technology company, today announced that... Read more.
Median Technologies’ Global iCRO Team to participate in the 2023 ESMO Congress, Oct 20 – 24, 2023, Madrid, Spain
The iCRO team will be available at Booth #552, Exhibition Hall 5 during the entire industry exhibition duration. Members of the Median Technologies’ team across... Read more.
OSE Immunotherapeutics Presents First Positive Clinical Results With its anti-PD1 OSE-279 in Advanced Solid Tumors
NANTES, France–(BUSINESS WIRE)–Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) presented the first Phase 1/2 positive clinical... Read more.
Gilead Demonstrates the Impact of Global Collaboration in Advancing HIV Research and Health Equity at EACS 2023
– Long-Term & Real-World HIV Research Offer Insights into How Treatment with Biktarvy® and Sunlenca® May Help Inform the Future of Coordinated, Person-Centered... Read more.
ABIONYX Pharma RACERS Study in Sepsis Selected for Late-Breaking Clinical Results Poster Presentation at the American Society of Nephrology (ASN) 2023 Annual Meeting “Kidney Week”
The late-breaking clinical results session will reveal exclusively RACERS’ Phase 2a clinical data in sepsis that met primary and secondary endpoints Two additional... Read more.
Innate Pharma Announces Abstracts Selected for ESMO Congress 2023
Sanofi’s ongoing SAR’579/IPH6101 Phase 1/2 trial in hematologic malignancies selected for oral presentation Presentations under the AstraZeneca collaboration... Read more.
Global Cybersecurity Leader eSentire Extends its Award-Winning 24/7 Security Operations Center as a Service (SOCaaS) Protection to Organizations Across the United Arab Emirates
eSentire’s localized Managed Detection and Response service prevents business disruption and complies with multiple federal decrees for data privacy, use of information... Read more.